Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P080010/S032

TECNIS Multi-focal 3-pc, Model ZMA00

Johnson & Johnson Surgical Vision, Inc. · Decision date Oct 19, 2026

MEDTECHLEDGER EXPLANATIONP080010/S032

What did the FDA decide?

The FDA record for P080010/S032 covers the TECNIS Multi-focal 3-pc, Model ZMA00, a multifocal intraocular lens in the ophthalmic specialty under product code MFK, submitted by Johnson & Johnson Surgical Vision, Inc. The supplement is a 30-Day Notice filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the recorded decision is OK30, dated 2026-10-19.

The recorded change is the transfer of microbiology testing from an external contractor to an in-house laboratory supporting product manufacturing at the AMO Puerto Rico manufacturing site. This notice concerns that testing-location change within the existing application; it is not a new approval of the lens itself. The public documentation includes no documents, so the notice's technical content and any FDA review detail beyond the recorded fields remain unknown.

Whether the in-house laboratory's methods, validation data or inspection outcome were assessed is not stated in the available record, and no clinical or legal conclusion about the device should be drawn from this administrative entry.

FDA approval order statement

the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Oct 19, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P080010/S032
Regulatory pathway
PMA supplement
Product code
MFK
Decision code
OK30
Decision date
Oct 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, multifocal intraocular.

Product code
MFK
FDA device class
3

For the original device and its historical approval scope, see PMA P080010. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P080010 · Original PMA

    TECNIS MULTIFOCAL FOLDABLE POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)

  2. P080010/S032 received

    Application receipt date recorded by FDA.

  3. P080010/S032 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P080010. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P080010

Product / regulatory recordCompanyPathwayDecision dateSource
Johnson & Johnson Surgical Vision, Inc.PMA approvalJan 16, 2009FDA

Explore the linked device profile

Other records with product code MFK

Product / regulatory recordCompanyPathwayDecision dateSource
Lenstec, Inc.PMA supplementOct 23, 2026FDA
Bausch + Lomb, Inc.PMA supplementOct 23, 2026FDA
Bausch + Lomb, Inc.PMA supplementOct 14, 2026FDA
Bausch + Lomb, Inc.PMA supplementSep 30, 2026FDA
Rayner Intraocular Lenses , Ltd.PMA supplementSep 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Johnson & Johnson Surgical Vision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records